These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31911024)

  • 1. New psychoactive substance use as a survival strategy in rural marginalised communities in Hungary.
    Csák R; Szécsi J; Kassai S; Márványkövi F; Rácz J
    Int J Drug Policy; 2020 Nov; 85():102639. PubMed ID: 31911024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motives for using new psychoactive substances in three groups of Polish users: nightlife, marginalised and active on the In.
    Wieczorek Ł; Dąbrowska K; Bujalski M
    Psychiatr Pol; 2022 Jun; 56(3):453-470. PubMed ID: 36342979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
    Palamar JJ; Su MK; Hoffman RS
    Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cloud on the horizon-a survey into the use of electronic vaping devices for recreational drug and new psychoactive substance (NPS) administration.
    Blundell M; Dargan P; Wood D
    QJM; 2018 Jan; 111(1):9-14. PubMed ID: 29025078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
    Yoganathan P; Claridge H; Chester L; Englund A; Kalk NJ; Copeland CS
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):516-525. PubMed ID: 33998886
    [No Abstract]   [Full Text] [Related]  

  • 6. Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.
    Van Hout MC; Benschop A; Bujalski M; Dąbrowska K; Demetrovics Z; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Korf D; Silva JP; Wieczorek Ł; Werse B
    Int J Ment Health Addict; 2018; 16(2):480-495. PubMed ID: 29674947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones.
    Péterfi A; Tarján A; Horváth GC; Csesztregi T; Nyírády A
    Drug Test Anal; 2014; 6(7-8):825-31. PubMed ID: 24692417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative consequences of novel psychoactive substances use among the Polish users.
    Wieczorek Ł; Bujalski M; Dąbrowska K
    Psychiatr Pol; 2021 Apr; 55(2):447-469. PubMed ID: 34365491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?
    Smith KE; Staton M
    Subst Abus; 2019; 40(2):160-169. PubMed ID: 30457960
    [No Abstract]   [Full Text] [Related]  

  • 10. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 11. The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.
    Jackson MA; Brown AL; Johnston J; Clancy R; McGregor I; Bruno R; Lintzeris N; Montebello M; Luksza J; Bowman J; Phung N; Allsop D; Dunlop AJ
    J Cannabis Res; 2021 Jul; 3(1):33. PubMed ID: 34311790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
    Cairns R; Brown JA; Gunja N; Buckley NA
    Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014.
    Rácz J; Csák R; Tóth KT; Tóth E; Rozmán K; Gyarmathy VA
    Drug Alcohol Depend; 2016 Jan; 158():154-8. PubMed ID: 26652897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
    Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
    J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.
    Kurcevič E; Lines R
    Harm Reduct J; 2020 Nov; 17(1):94. PubMed ID: 33256747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M
    Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
    Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
    Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.
    Benschop A; Urbán R; Kapitány-Fövény M; Van Hout MC; Dąbrowska K; Felvinczi K; Hearne E; Henriques S; Kaló Z; Kamphausen G; Silva JP; Wieczorek Ł; Werse B; Bujalski M; Korf D; Demetrovics Z
    J Psychopharmacol; 2020 Jun; 34(6):600-611. PubMed ID: 32043399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas.
    Martinotti G; Lupi M; Carlucci L; Cinosi E; Santacroce R; Acciavatti T; Chillemi E; Bonifaci L; Janiri L; Di Giannantonio M
    Hum Psychopharmacol; 2015 Jul; 30(4):295-301. PubMed ID: 26216566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.